Indivisible Partners Purchases New Shares in Merck & Co., Inc. $MRK

Indivisible Partners recently acquired 12,823 new shares of Merck & Co., Inc. valued at approximately $1.35 million. Institutional investors now collectively own 76.07% of Merck, with Vanguard Group being a major holder. The company recently reported strong Q4 results, beating EPS and revenue estimates, and completed the acquisition of Terns Pharmaceuticals to enhance its oncology pipeline.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin